Your browser doesn't support javascript.
loading
Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells.
Freeman, Taylor J; Sayedyahossein, Samar; Johnston, Danielle; Sanchez-Pupo, Rafael E; O'Donnell, Brooke; Huang, Kenneth; Lakhani, Zameena; Nouri-Nejad, Daniel; Barr, Kevin J; Harland, Luke; Latosinsky, Steven; Grant, Aaron; Dagnino, Lina; Penuela, Silvia.
Affiliation
  • Freeman TJ; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. tayfreem3@gmail.com.
  • Sayedyahossein S; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. ssayedy@uwo.ca.
  • Johnston D; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. Danielle.Johnston@schulich.uwo.ca.
  • Sanchez-Pupo RE; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. rsnchezp@uwo.ca.
  • O'Donnell B; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. bodonne3@uwo.ca.
  • Huang K; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. khuang85@uwo.ca.
  • Lakhani Z; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. zlakhan3@uwo.ca.
  • Nouri-Nejad D; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. dnourin@uwo.ca.
  • Barr KJ; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. kevin.barr@schulich.uwo.ca.
  • Harland L; Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. luke.harland@trinity.ox.ac.uk.
  • Latosinsky S; Surgery, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. steven.latosinsky@lhsc.on.ca.
  • Grant A; Surgery, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. Aaron.Grant@lhsc.on.ca.
  • Dagnino L; Physiology and Pharmacology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. ldagnino@uwo.ca.
  • Penuela S; Oncology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, Canada. ldagnino@uwo.ca.
Cancers (Basel) ; 11(1)2019 Jan 16.
Article in En | MEDLINE | ID: mdl-30654593
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Canada Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2019 Document type: Article Affiliation country: Canada Country of publication: Switzerland